Thus, the greater non-mitochondrial oxygen consumption observed in VAT of patients with obesity class 3 could result from the activity of pro-oxidant and pro-inflammatory enzymes, such as cyclo-oxygenases, cytochrome P450 or NADPH oxidases, suggesting a greater inflammatory activity [16]. The gene discussed is FMO5; the disease is obesity disorder.